“Potential Collaborative Markers for Nasopharyngeal Carcinoma Diagnosis and Therapy: AGR2 and AKR1B10” (2025) Clinical Medicine and Pharmacology, 2(1), pp. 1–7. doi:10.70731/rek12e38.